Costanzo A - Search Results

1

Effects of TNF-α inhibition on pre-clinical enthesitis: observational study on 49 psoriatic patients.

Narcisi A, Valenti M, De Simone C, Esposito M, Richetta A, Teoli M, Argento G, Costanzo A. Narcisi A, et al. Among authors: costanzo a. J Dermatolog Treat. 2022 May;33(3):1703-1706. doi: 10.1080/09546634.2021.1899112. Epub 2021 Mar 10. J Dermatolog Treat. 2022. PMID: 33691568 Free article.

2

Treatment of vitiligo with the 308 nm excimer laser.

Esposito M, Soda R, Costanzo A, Chimenti S. Esposito M, et al. Among authors: costanzo a. Clin Exp Dermatol. 2004 Mar;29(2):133-7. doi: 10.1111/j.1365-2230.2004.01477.x. Clin Exp Dermatol. 2004. PMID: 14987266

3

Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics.

Papoutsaki M, Chimenti MS, Costanzo A, Talamonti M, Zangrilli A, Giunta A, Bianchi L, Chimenti S. Papoutsaki M, et al. Among authors: costanzo a. J Am Acad Dermatol. 2007 Aug;57(2):269-75. doi: 10.1016/j.jaad.2006.12.003. Epub 2007 Jun 18. J Am Acad Dermatol. 2007. PMID: 17574299 Clinical Trial.

4

Adalimumab for the treatment of severe psoriasis and psoriatic arthritis.

Papoutsaki M, Costanzo A, Chimenti MS, Chimenti S. Papoutsaki M, et al. Among authors: costanzo a. Expert Opin Biol Ther. 2008 Mar;8(3):363-70. doi: 10.1517/14712598.8.3.363. Expert Opin Biol Ther. 2008. PMID: 18294106 Review.

5

Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.

Mazzotta A, Esposito M, Costanzo A, Chimenti S. Mazzotta A, et al. Among authors: costanzo a. Am J Clin Dermatol. 2009;10(5):319-24. doi: 10.2165/11310770-000000000-00000. Am J Clin Dermatol. 2009. PMID: 19658444 Clinical Trial.

6

Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis.

Caruso R, Botti E, Sarra M, Esposito M, Stolfi C, Diluvio L, Giustizieri ML, Pacciani V, Mazzotta A, Campione E, Macdonald TT, Chimenti S, Pallone F, Costanzo A, Monteleone G. Caruso R, et al. Among authors: costanzo a. Nat Med. 2009 Sep;15(9):1013-5. doi: 10.1038/nm.1995. Epub 2009 Aug 16. Nat Med. 2009. PMID: 19684581

7

The impact of methodological approaches for presenting long-term clinical data on estimates of efficacy in psoriasis illustrated by three-year treatment data on infliximab.

Papoutsaki M, Talamonti M, Giunta A, Costanzo A, Ruzzetti M, Teoli M, Chimenti S. Papoutsaki M, et al. Among authors: costanzo a. Dermatology. 2010;221 Suppl 1:43-7. doi: 10.1159/000316184. Epub 2010 Aug 9. Dermatology. 2010. PMID: 20733314

8

Patients with moderate to severe plaque psoriasis: one year after the European Medicines Agency recommendation of efalizumab suspension.

Talamonti M, Teoli M, Botti E, Spallone G, Chimenti S, Costanzo A. Talamonti M, et al. Among authors: costanzo a. Dermatology. 2011;222(3):250-5. doi: 10.1159/000326111. Epub 2011 Apr 13. Dermatology. 2011. PMID: 21494026

9

Ustekinumab for treatment of plaque psoriasis in a patient with Down syndrome.

Talamonti M, Galluzzo M, Chiricozzi A, Teoli M, Bavetta M, Costanzo A, Chimenti S. Talamonti M, et al. Among authors: costanzo a. J Drugs Dermatol. 2012 Aug;11(8):1000-2. J Drugs Dermatol. 2012. PMID: 22859249

10

Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab.

Talamonti M, Botti E, Galluzzo M, Teoli M, Spallone G, Bavetta M, Chimenti S, Costanzo A. Talamonti M, et al. Among authors: costanzo a. Br J Dermatol. 2013 Aug;169(2):458-63. doi: 10.1111/bjd.12331. Br J Dermatol. 2013. PMID: 23521149

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

850 results

Search Page

Filters